Edition:
India

Erytech Pharma SA (ERYP.PA)

ERYP.PA on Paris Stock Exchange

5.83EUR
2:31pm IST
Change (% chg)

€-0.10 (-1.69%)
Prev Close
€5.93
Open
€5.92
Day's High
€5.93
Day's Low
€5.79
Volume
9,649
Avg. Vol
27,321
52-wk High
€9.86
52-wk Low
€5.61

About

Erytech Pharma SA, also known as ERYTECH Pharma, is a France-based biopharmaceutical company developing medicinal products mainly in oncology, hematology and immunology fields of business. The Company offers ESY-ASP (GRASPA), a medicinal product consisting of L-Asparaginase entrapped into human homologous red blood cells. The... (more)

Overall

Beta: 1.33
Market Cap(Mil.): €106.37
Shares Outstanding(Mil.): 17.94
Dividend: --
Yield (%): --

Financials

BRIEF-Erytech Announces Immune Modulation Strategic Collaboration With SQZ Biotechnologies

* ERYTECH ANNOUNCED ON MONDAY IT HAS ENTERED INTO AN AGREEMENT WITH SQZ BIOTECHNOLOGIES TO ADVANCE NOVEL RBC-BASED THERAPEUTICS FOR IMMUNE MODULATION

25 Jun 2019

BRIEF-Erytech Pharma Presents New Erymethionase Preclinical Findings

* ERYTECH SAID ON MONDAY IT PRESENTED NEW ERYMETHIONASE PRECLINICAL FINDINGS AT 2019 AACR ANNUAL MEETING

02 Apr 2019

BRIEF- Erytech Pharma FY Total Operating Loss Widens To 43.6 Million Euros

* ANNOUNCED ON MONDAY, ERYTECH PROVIDES BUSINESS UPDATE AND REPORTS FINANCIAL RESULTS FOR FULL YEAR 2018

12 Mar 2019

Earnings vs. Estimates